Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#151 / 200 Total
SGMT - Sagimet Biosciences Inc - Stock Price Chart
TickerSGMT [NASD, RUT]
CompanySagimet Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap142.04MEPS (ttm)-1.28
P/E-EPS this Y22.74%
Forward P/E-EPS next Y-81.70%
PEG-EPS past 5Y-16.23%
P/S71.02EPS next 5Y-
P/B1.12EPS Q/Q12.87%
Dividend-Sales Q/Q-
Insider Own46.04%Inst Own37.78%
Insider Trans0.10%Inst Trans-
Short Float12.01%EarningsMar 25/b
Analyst Recom1.00Target Price40.00
Avg Volume991.23K52W Range2.13 - 20.71
TodayInitiated H.C. Wainwright Buy $32
Apr-22-24 08:00AM Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024 (GlobeNewswire)
Mar-27-24 04:01PM Sagimet Biosciences Announces Completion of Phase 1 Hepatic Impairment Study with FASN Inhibitor Denifanstat (GlobeNewswire) +9.56%
Mar-25-24 07:00AM Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors (GlobeNewswire) +15.74%
06:15AM Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates (GlobeNewswire)
Feb-29-24 08:00AM Sagimet Biosciences to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Jan-25-24 08:58PM Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock (GlobeNewswire) -13.62%
Jan-23-24 05:45PM Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock (GlobeNewswire)
Jan-22-24 11:10PM Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH (PR Newswire) +170.09%
07:00AM Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH (GlobeNewswire)
Dec-04-23 08:00AM Sagimet Biosciences to Participate in the First Annual Goldman Sachs Catalyst Clinic (GlobeNewswire) +7.12%
RGLS - Regulus Therapeutics Inc - Stock Price Chart
TickerRGLS [NASD]
CompanyRegulus Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap176.11MEPS (ttm)-1.59
P/E-EPS this Y67.83%
Forward P/E-EPS next Y-19.90%
PEG-EPS past 5Y50.96%
P/S-EPS next 5Y39.60%
P/B2.57EPS Q/Q1.21%
Dividend-Sales Q/Q-
Insider Own12.29%Inst Own24.86%
Insider Trans-0.32%Inst Trans6.45%
Short Float10.93%EarningsMar 21/a
Analyst Recom1.50Target Price7.25
Avg Volume3.13M52W Range1.08 - 3.79
Apr-30-24 08:00AM Regulus Therapeutics to Participate in the Canaccord Genuity Genetic Medicine for Generalists Webcast Series (PR Newswire) -8.73%
Mar-23-24 05:33AM Regulus Therapeutics Inc (RGLS) Reports Year-End Earnings, Highlights Key Clinical Advancements (GuruFocus.com)
Mar-21-24 10:53PM RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023 (InvestorPlace) +11.20%
04:22PM Regulus: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates (PR Newswire)
Mar-13-24 12:09PM Regulus (RGLS) Up 71% on Topline Data from Kidney Disease Study (Zacks)
Mar-12-24 06:32AM Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity (PR Newswire) +71.01%
06:30AM Regulus Therapeutics Announces Positive Topline Data from the Second Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) (PR Newswire)
Jan-02-24 04:05PM Regulus Therapeutics Announces Completion of Enrollment in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD) (PR Newswire)
Nov-22-23 08:00AM Regulus Therapeutics to Present at the 6th Annual Evercore ISI HealthCONx Conference (PR Newswire) -5.11%
CTMX - CytomX Therapeutics Inc - Stock Price Chart
TickerCTMX [NASD]
CompanyCytomX Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap304.74MEPS (ttm)-0.02
P/E-EPS this Y-3686.00%
Forward P/E-EPS next Y-11.90%
PEG-EPS past 5Y67.21%
P/S3.01EPS next 5Y-0.90%
P/B-EPS Q/Q109.36%
Dividend-Sales Q/Q32.22%
Insider Own1.84%Inst Own48.12%
Insider Trans-5.72%Inst Trans-20.06%
Short Float5.41%EarningsMar 11/a
Analyst Recom2.86Target Price2.85
Avg Volume4.27M52W Range1.04 - 5.85
Today 08:08AM CytomX Therapeutics (CTMX) Surges 214.7%: Is This an Indication of Further Gains? (Zacks) -12.28%
07:37AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
May-01-24 12:11PM Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally (InvestorPlace) +214.72%
11:43AM Why Is CytomX (CTMX) Stock Up 180% Today? (InvestorPlace)
08:00AM CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024 (GlobeNewswire)
Apr-08-24 08:00AM CytomX Therapeutics Announces First Patient Dosed with CX-2051, a Conditionally Activated EpCAM-Directed ADC, in a Phase 1 Study in Patients with Advanced Solid Tumors (GlobeNewswire)
Apr-03-24 08:00AM CytomX Therapeutics Announces Nomination of Second Clinical Candidate in Broad PROBODY T-Cell Engaging Bispecific (TCB) Collaboration with Astellas (GlobeNewswire)
Mar-21-24 08:00AM CytomX Therapeutics Appoints Dr. Zhen Su to Board of Directors (GlobeNewswire)
Mar-18-24 08:00AM CytomX Therapeutics Announces Milestone Achievement in PROBODY T-Cell Engaging Bispecific (TCB) Collaboration with Astellas (GlobeNewswire)
Mar-12-24 09:12AM Why Is CytomX Therapeutics (CTMX) Stock Down 18% Today? (InvestorPlace) -14.34%
BRTX - BioRestorative Therapies Inc - Stock Price Chart
TickerBRTX [NASD]
CompanyBioRestorative Therapies Inc
CountryUSA
IndustryBiotechnology
Market Cap9.88MEPS (ttm)-3.54
P/E-EPS this Y37.72%
Forward P/E-EPS next Y1.17%
PEG-EPS past 5Y77.95%
P/S65.89EPS next 5Y-
P/B0.60EPS Q/Q49.37%
Dividend-Sales Q/Q421.62%
Insider Own27.60%Inst Own11.39%
Insider Trans18.21%Inst Trans2.02%
Short Float0.82%Earnings-
Analyst Recom1.00Target Price10.50
Avg Volume962.48K52W Range1.20 - 7.13
Apr-30-24 04:15PM BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 (GlobeNewswire) +14.52%
07:30AM BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology (GlobeNewswire)
Apr-16-24 07:45AM BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment (GlobeNewswire)
Apr-14-24 03:00PM 10 Micro-Cap Healthcare Stocks Insiders Are Buying (Insider Monkey)
Apr-08-24 07:45AM BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease (GlobeNewswire)
Apr-03-24 04:38PM BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants (GlobeNewswire)
Apr-02-24 09:53AM BRTX Stock Earnings: BioRestorative Therapies Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
Apr-01-24 07:45AM BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K (GlobeNewswire)
Mar-11-24 04:15PM BioRestorative Therapies to Participate in the 36th Annual ROTH Conference (GlobeNewswire)
Feb-14-24 09:15AM BioRestorative Therapies Presents Promising Data at Orthopaedic Research Society (ORS) 2024 Annual Meeting (ACCESSWIRE)
SDA - SunCar Technology Group Inc - Stock Price Chart
TickerSDA [NASD]
CompanySunCar Technology Group Inc
CountryChina
IndustryAuto & Truck Dealerships
Market Cap748.93MEPS (ttm)0.18
P/E47.46EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B78.74EPS Q/Q56.47%
Dividend-Sales Q/Q-
Insider Own82.33%Inst Own0.13%
Insider Trans0.00%Inst Trans0.04%
Short Float0.77%EarningsApr 29/b
Analyst Recom-Target Price-
Avg Volume304.69K52W Range3.80 - 45.73
Apr-29-24 08:00AM SunCar Technology Reports 29% Revenue Growth, Including 79% Increase in Auto e-Insurance Business in FY 2023 (PR Newswire) +8.78%
Apr-24-24 09:16AM SunCar Technology Group Inc. Schedules Fiscal Year 2023 Earnings Conference Call on Tuesday, April 30th at 5 p.m. ET (PR Newswire) -5.03%
Apr-18-24 08:00AM SunCar Technology Group Inc. Elevates Luxury Travel with Exclusive Airport Concierge Service in Partnership with Ant Fortune (PR Newswire)
Apr-02-24 07:30AM SunCar Technology Group Inc. Partners with China CITIC Bank International to Elevate Private Banking Travel Experience (PR Newswire) +10.00%
Mar-07-24 08:00AM SunCar Technology Group Inc. Highlights Growth and Market Leadership at the Citizens JMP Technology Conference (PR Newswire)
Mar-04-24 07:30AM SunCar Technology Group Inc. to Present at the Citizens JMP Technology Conference (PR Newswire)
Feb-21-24 07:30AM SunCar Technology Group Inc. Announces Business Cooperation with Li Auto for Advanced System Software Development (PR Newswire)
Jan-22-24 08:30AM SunCar Technology Group Inc. Secures Exclusive Vehicle Service Contract with China Construction Bank's Sichuan Branch (PR Newswire)
Jan-08-24 08:30AM SunCar Technology Group Inc. Secures Exclusive Vehicle Service Contract with China Construction Bank (PR Newswire)
Dec-12-23 05:25AM Bank of America Is Great. Here's Why You Shouldn't Buy The Stock.. (Motley Fool)
SWVL - Swvl Holdings Corp - Stock Price Chart
TickerSWVL [NASD]
CompanySwvl Holdings Corp
CountryUnited Arab Emirates
IndustrySoftware - Application
Market Cap76.05MEPS (ttm)8.09
P/E1.38EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.86EPS next 5Y-
P/B9.41EPS Q/Q-90760.29%
Dividend-Sales Q/Q-
Insider Own46.03%Inst Own0.63%
Insider Trans0.00%Inst Trans-
Short Float1.83%EarningsDec 27/b
Analyst Recom3.00Target Price37.50
Avg Volume119.68K52W Range0.62 - 21.94
May-01-24 07:31AM Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace) -16.42%
Apr-30-24 06:00AM Swvl Records $3.1m Net Profit, 13% Net Margin, and an Eightfold Growth in Gross Profit (GlobeNewswire) +35.38%
Mar-08-24 05:20AM 15 Cities with the Worst Public Transportation in the US (Insider Monkey) -22.70%
Mar-06-24 03:04PM 15 European Cities with the Best Public Transportation (Insider Monkey) +11.39%
Dec-27-23 06:00AM Swvl Reports First Half 2023 Financial Results (GlobeNewswire) +36.07%
Dec-26-23 04:05PM Swvl Reports Receipt of Nasdaq Minimum Bid Price Notification (GlobeNewswire)
Sep-13-23 04:50AM Swvl Sells one of its Subsidiaries, Urbvan, to Kolors, To Leverage Sale Proceeds for Enhanced Strategic Expansion (GlobeNewswire) +11.65%
Jul-20-23 04:05PM Swvl Obtains Extension for Filing of Annual Report on Form 20-F and Receives Approval to Transfer to The Nasdaq Capital Market (GlobeNewswire)
Jun-20-23 06:00AM Swvl Regains Compliance with NASDAQ Continued Listing Requirements Relating to Audit Committee (GlobeNewswire) +5.26%
May-23-23 04:05PM Swvl Appoints Ayman Ismail to Board of Directors as Independent Member and Chairperson of Audit Committee (GlobeNewswire)
MRAI - Marpai Inc - Stock Price Chart
TickerMRAI [NASD]
CompanyMarpai Inc
CountryUSA
IndustryHealthcare Plans
Market Cap25.07MEPS (ttm)-4.41
P/E-EPS this Y64.49%
Forward P/E-EPS next Y72.79%
PEG-EPS past 5Y-87.80%
P/S0.67EPS next 5Y-
P/B-EPS Q/Q60.60%
Dividend-Sales Q/Q14.14%
Insider Own50.15%Inst Own2.30%
Insider Trans113.34%Inst Trans-10.43%
Short Float2.27%EarningsMar 26/a
Analyst Recom1.00Target Price6.00
Avg Volume418.18K52W Range0.33 - 3.46
Today 06:00AM MARPAI INC. ANNOUNCES COST REDUCTION PROGRAM AND PROPERTY SUBLEASE (PR Newswire) +16.46%
Apr-24-24 11:03AM MARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVES (PR Newswire)
Apr-16-24 11:59AM MARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTES (PR Newswire) +6.59%
Mar-28-24 09:33AM Marpai, Inc. (NASDAQ:MRAI) Q4 2023 Earnings Call Transcript (Insider Monkey) +17.31%
Mar-27-24 09:33PM Q4 2023 Marpai Inc Earnings Call (Thomson Reuters StreetEvents) -12.24%
Mar-26-24 09:54PM MRAI Stock Earnings: Marpai Misses Revenue for Q4 2023 (InvestorPlace) +16.18%
04:01PM MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS (PR Newswire)
Mar-13-24 07:00AM NASDAQ PANEL GRANTS MARPAI'S REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING REQUIREMENTS (PR Newswire) +17.26%
Mar-12-24 05:34PM 11 Stocks Insiders are Buying Now (Insider Monkey) +15.31%
Mar-06-24 06:00AM MARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023 (PR Newswire) +28.76%
PARA - Paramount Global - Stock Price Chart
TickerPARA [NASD, S&P 500]
CompanyParamount Global
CountryUSA
IndustryEntertainment
Market Cap9.24BEPS (ttm)-0.82
P/E-EPS this Y142.67%
Forward P/E9.92EPS next Y10.74%
PEG-EPS past 5Y-
P/S0.31EPS next 5Y54.87%
P/B0.41EPS Q/Q50.05%
Dividend1.46%Sales Q/Q5.78%
Insider Own11.27%Inst Own73.05%
Insider Trans0.00%Inst Trans1.96%
Short Float12.27%EarningsApr 29/a
Analyst Recom3.10Target Price13.37
Avg Volume20.28M52W Range10.12 - 23.45
Today 03:52PM Paramount pops on reports of Apollo, Sony $26B takeover bid (Yahoo Finance Video) +13.05%
02:18PM Sony and Apollo want to buy Paramount for $26 billion in cash (Quartz)
02:09PM Sony, Apollo Make $26 Billion All-Cash Offer for Paramount (The Wall Street Journal)
01:40PM Paramount Stock Jumps After Report of $26 Billion Offer by Sony, Apollo (The Wall Street Journal)
12:51PM Paramount shareholder raises dilution concerns in Skydance bid (Yahoo Finance Video)
11:38AM 456 BILLION MINUTES OF CBS PROGRAMMING WATCHED IN THE FIRST FOUR MONTHS OF 2024 (PR Newswire)
07:22AM 3 Contrarian Stocks That Could Make You a Fortune (If You Dare) (InvestorPlace)
May-01-24 08:33AM What You Need To Know Ahead of Warren Buffett's Berkshire Hathaway Annual Meeting (Investopedia) +7.64%
Apr-30-24 04:34PM Warner Bros. Discovery could be losing NBA TV rights to NBC (Yahoo Finance Video) -7.02%
03:44PM Stock Market Crash Warning: Don't Get Caught Holding These 3 Warren Buffett Stocks (InvestorPlace)
SMXT - SolarMax Technology Inc. - Stock Price Chart
TickerSMXT [NASD]
CompanySolarMax Technology Inc.
CountryUSA
IndustrySolar
Market Cap466.61MEPS (ttm)0.01
P/E1068.04EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S8.62EPS next 5Y-
P/B-EPS Q/Q-89.27%
Dividend-Sales Q/Q-15.21%
Insider Own39.30%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.30%Earnings-
Analyst Recom-Target Price-
Avg Volume289.04K52W Range3.50 - 15.88
Apr-16-24 07:35PM SolarMax Technology, Inc. Reports Fiscal Year 2023 Financial Results (ACCESSWIRE) -18.58%
Apr-11-24 05:00AM 4 Stocks For A Decarbonized Future (News Direct) +14.90%
Mar-05-24 04:01PM SolarMax Technology, Inc. Announces Exercise of Overallotment Option From Initial Public Offering (GlobeNewswire) +12.88%
Feb-29-24 01:30PM SolarMax Technology, Inc. Announces Closing of Initial Public Offering (GlobeNewswire) -16.55%
Feb-27-24 12:51PM SolarMax Technology, Inc. Announces Pricing of Initial Public Offering and listing on Nasdaq (PR Newswire)
BNTC - Benitec Biopharma Inc - Stock Price Chart
TickerBNTC [NASD]
CompanyBenitec Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap22.97MEPS (ttm)-10.90
P/E-EPS this Y82.79%
Forward P/E-EPS next Y27.98%
PEG-EPS past 5Y66.41%
P/S382.83EPS next 5Y-
P/B1.49EPS Q/Q20.94%
Dividend-Sales Q/Q-100.00%
Insider Own6.81%Inst Own46.32%
Insider Trans0.00%Inst Trans-
Short Float0.51%EarningsFeb 13/b
Analyst Recom1.00Target Price16.00
Avg Volume86.50K52W Range1.86 - 9.01
May-01-24 08:00AM Benitec Biopharma to Participate in the Citizens JMP Life Science Conference (GlobeNewswire) -6.51%
Apr-18-24 07:30AM Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study (GlobeNewswire) +42.08%
07:00AM Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million (GlobeNewswire)
Apr-09-24 08:00AM Benitec Biopharma to Host Virtual R&D Day to Discuss BB-301 Clinical Program in Oculopharyngeal Muscular Dystrophy on April 18, 2024 (GlobeNewswire)
Mar-24-24 07:55AM 11 Best ASX Stocks To Buy Now (Insider Monkey)
Feb-13-24 08:00AM Benitec Biopharma Releases Second Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Nov-30-23 07:00AM Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy (GlobeNewswire)
Nov-17-23 08:00AM Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 08:00AM Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update (GlobeNewswire)
Sep-21-23 08:00AM Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update (GlobeNewswire)
1⋯1011121314151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.